| Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today announced that it has secured £3.5m in new equity financing, including £2.5m from lead investor |
Tia... ekarD selbmeseR ohW noS gnidulBitcoin... TDSU rof CTB eroM yuB ot rehteFans... gnitaD erA yenoroM nageM ,neerMan... eniaG leahciM remraf yrreK foPolitical... strepxe :tcejorp erutpac nobraEgyptian... srehto dna hceTpursiD ,srentraElon... stsoc enimaxe ot evreseR laredDiablo... 'kresreB' agnam ysatnaf krad yAndrew... CYN ni gnitov nees omouC werdnLuisita,... mA liF ’sroines ni emerpus ngi